Australia - Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingPrice for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Australia - 2023
Contents:
- Price for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Australia (CIF) - 2022
- Price for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Australia (FOB) - 2022
- Imports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Australia
- Exports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Australia
Price for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Australia (CIF) - 2022
In 2022, the average import price for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses amounted to $2,967 per ton, waning by -76.8% against the previous year. In general, the import price recorded a abrupt slump. The pace of growth appeared the most rapid in 2020 when the average import price increased by 164%. The import price peaked at $18,322 per ton in 2017; however, from 2018 to 2022, import prices remained at a lower figure.
Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Ireland ($93,392 per ton), while the price for Italy ($1,035 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Ireland (+12.4%), while the prices for the other major suppliers experienced more modest paces of growth.
Price for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Australia (FOB) - 2022
The average export price for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses stood at $41,773 per ton in 2022, with a decrease of -39.8% against the previous year. Overall, the export price recorded a noticeable decline. The pace of growth appeared the most rapid in 2018 an increase of 97% against the previous year. As a result, the export price reached the peak level of $93,723 per ton. From 2019 to 2022, the average export prices remained at a lower figure.
Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was the UK ($876,430 per ton), while the average price for exports to China ($7,937 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to the UK (+29.4%), while the prices for the other major destinations experienced more modest paces of growth.
Imports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Australia
Imports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses into Australia surged to 17K tons in 2022, jumping by 294% against 2021. In general, imports continue to indicate a significant expansion. As a result, imports attained the peak and are likely to continue growth in the immediate term.
In value terms, imports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses contracted to $50M in 2022. Over the period under review, imports continue to indicate prominent growth. The pace of growth appeared the most rapid in 2021 with an increase of 93% against the previous year. As a result, imports reached the peak of $55M, and then contracted in the following year.
| Import of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Australia (Million USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| Italy | 7.4 | 0.9 | 1.2 | 15.0 | 26.6% |
| China | 5.8 | 10.8 | 9.2 | 8.0 | 11.3% |
| Switzerland | N/A | 3.4 | 23.1 | 7.9 | 52.4% |
| Others | 18.6 | 13.3 | 21.6 | 19.3 | 1.2% |
| Total | 31.8 | 28.4 | 55.0 | 50.3 | 16.5% |
Top Suppliers of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses to Australia in 2022:
- Italy (14.5K tons)
- China (1.7K tons)
- Switzerland (0.4K tons)
Exports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Australia
In 2022, exports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses from Australia skyrocketed to 925 tons, rising by 136% on the previous year. In general, exports enjoyed a strong expansion. As a result, the exports reached the peak and are likely to continue growth in the immediate term.
In value terms, exports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses soared to $39M in 2022. Over the period under review, exports, however, continue to indicate a abrupt decrease.
| Export of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses in Australia (Million USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| New Zealand | 4.8 | 5.1 | 4.9 | 14.1 | 43.2% |
| Hong Kong SAR | 3.3 | 1.6 | 0.4 | 3.0 | -3.1% |
| Singapore | 6.2 | 0.8 | 1.4 | 1.8 | -33.8% |
| Japan | N/A | 0.1 | 0.6 | 1.0 | 216.2% |
| New Caledonia | N/A | N/A | N/A | 0.5 | 0% |
| Taiwan (Chinese) | 0.6 | 0.3 | 0.4 | 0.1 | -45.0% |
| Fiji | 0.5 | 0.2 | N/A | 0.1 | -41.5% |
| China | 4.8 | 0.6 | N/A | N/A | -87.5% |
| Others | 35.1 | 13.6 | 19.6 | 17.9 | -20.1% |
| Total | 55.4 | 22.2 | 27.2 | 38.7 | -11.3% |
Top Export Markets for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses from Australia in 2022:
- New Zealand (671.9 tons)
- Japan (64.2 tons)
- Singapore (55.7 tons)
- Hong Kong SAR (38.0 tons)
- New Caledonia (21.0 tons)
- Taiwan (Chinese) (7.9 tons)
- Fiji (6.3 tons)
- China (1.0 tons)
This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in Australia. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201320 - Other medicaments for therapeutic or prophylactic uses, of HS
Country coverage:
- Australia
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Australia
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
200
This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in Australia.
348
This report provides an in-depth analysis of the medicaments containing hormones market in Australia.
427
This report provides an in-depth analysis of the medicaments containing insulin market in Australia.
395
This report provides an in-depth analysis of the medicaments containing penicillin market in Australia.
235
This report provides an in-depth analysis of the market for medicaments of alkaloids or derivatives thereof in Australia.
225
This report provides an in-depth analysis of the market for non-penicillin or streptomycin antibiotic medicaments in Australia.
309
This report provides an in-depth analysis of the global market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses.
486
This report provides an in-depth analysis of the global medicaments containing hormones market.
480
This report provides an in-depth analysis of the global medicaments containing insulin market.
582
This report provides an in-depth analysis of the global medicaments containing penicillin market.
107
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.
107
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.
